Diplomat Pharmacy (DPLO) Misses Q3 EPS by 22c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts DPLO Hot Sheet
Join SI Premium – FREE
Diplomat Pharmacy (NYSE: DPLO) reported Q3 EPS of $0.00, $0.22 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.42 billion.
GUIDANCE:
Diplomat Pharmacy sees 2018 EPS of ($0.10)-$0.03, versus the consensus of $0.83. Diplomat Pharmacy sees 2018 revenue of $5.5-5.7 billion, versus the consensus of $5.64 billion.
For earnings history and earnings-related data on Diplomat Pharmacy (DPLO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Lear Corp. (LEA) Tops Q3 EPS by 39c ; Offers Guidance
- Cboe Global Markets (CBOE) Tops Q3 EPS by 21c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
